Developing 3D Organized Human Cardiac Tissue within a Microfluidic Platform

被引:7
作者
Veldhuizen, Jaimeson [1 ]
Nikkhah, Mehdi [1 ,2 ]
机构
[1] Arizona State Univ, Sch Biol & Hlth Syst Engn, Tempe, AZ 85287 USA
[2] Arizona State Univ, Biodesign Virginia G Piper Ctr Personalized Diagn, Tempe, AZ 85287 USA
来源
JOVE-JOURNAL OF VISUALIZED EXPERIMENTS | 2021年 / 172期
基金
美国国家科学基金会;
关键词
PLURIPOTENT STEM-CELLS; CURRENT-STRATEGIES; CARDIOMYOCYTES; MATURATION; CULTURE; PDMS; DIFFERENTIATION; PURIFICATION; MACROPHAGES; HEART;
D O I
10.3791/62539
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The leading cause of death worldwide persists as cardiovascular disease (CVD). However, modeling the physiological and biological complexity of the heart muscle, the myocardium, is notoriously difficult to accomplish in vitro. Mainly, obstacles lie in the need for human cardiomyocytes (CMs) that are either adult or exhibit adult-like phenotypes and can successfully replicate the myocardium's cellular complexity and intricate 3D architecture. Unfortunately, due to ethical concerns and lack of available primary patient-derived human cardiac tissue, combined with the minimal proliferation of CMs, the sourcing of viable human CMs has been a limiting step for cardiac tissue engineering. To this end, most research has transitioned toward cardiac differentiation of human induced pluripotent stem cells (hiPSCs) as the primary source of human CMs, resulting in the wide incorporation of hiPSC-CMs within in vitro assays for cardiac tissue modeling. Here in this work, we demonstrate a protocol for developing a 3D mature stem cell-derived human cardiac tissue within a microfluidic device. We specifically explain and visually demonstrate the production of a 3D in vitro anisotropic cardiac tissue-on-a-chip model from hiPSC-derived CMs. We primarily describe a purification protocol to select for CMs, the co-culture of cells with a defined ratio via mixing CMs with human CFs (hCFs), and suspension of this co-culture within the collagen-based hydrogel. We further demonstrate the injection of the cell-laden hydrogel within our well-defined microfluidic device, embedded with staggered elliptical microposts that serve as surface topography to induce a high degree of alignment of the surrounding cells and the hydrogel matrix, mimicking the architecture of the native myocardium. We envision that the proposed 3D anisotropic cardiac tissue-on-chip model is suitable for fundamental biology studies, disease modeling, and, through its use as a screening tool, pharmaceutical testing.
引用
收藏
页数:20
相关论文
共 56 条
[1]  
Achberger, 2021, ACS BIOMATER SCI ENG
[2]   Microfluidic heart on a chip for higher throughput pharmacological studies [J].
Agarwal, Ashutosh ;
Goss, Josue Adrian ;
Cho, Alexander ;
McCain, Megan Laura ;
Parker, Kevin Kit .
LAB ON A CHIP, 2013, 13 (18) :3599-3608
[3]   Current Strategies and Challenges for Purification of Cardiomyocytes Derived from Human Pluripotent Stem Cells [J].
Ban, Kiwon ;
Bae, Seongho ;
Yoon, Young-sup .
THERANOSTICS, 2017, 7 (07) :2067-2077
[4]   Engineered In Vitro Disease Models [J].
Benam, Kambez H. ;
Dauth, Stephanie ;
Hassell, Bryan ;
Herland, Anna ;
Jain, Abhishek ;
Jang, Kyung-Jin ;
Karalis, Katia ;
Kim, Hyun Jung ;
MacQueen, Luke ;
Mahmoodian, Roza ;
Musah, Samira ;
Torisawa, Yu-suke ;
van der Meer, Andries D. ;
Villenave, Remi ;
Yadid, Moran ;
Parker, Kevin K. ;
Ingber, Donald E. .
ANNUAL REVIEW OF PATHOLOGY: MECHANISMS OF DISEASE, VOL 10, 2015, 10 :195-262
[5]   Engineers are from PDMS-land, Biologists are from Polystyrenia [J].
Berthier, Erwin ;
Young, Edmond W. K. ;
Beebe, David .
LAB ON A CHIP, 2012, 12 (07) :1224-1237
[6]   Three-dimensional cell culture: the missing link in drug discovery [J].
Breslin, Susan ;
O'Driscoll, Lorraine .
DRUG DISCOVERY TODAY, 2013, 18 (5-6) :240-249
[7]   Production of De Novo Cardiomyocytes: Human Pluripotent Stem Cell Differentiation and Direct Reprogramming [J].
Burridge, Paul W. ;
Keller, Gordon ;
Gold, Joseph D. ;
Wu, Joseph C. .
CELL STEM CELL, 2012, 10 (01) :16-28
[8]   Origins and implications of pluripotent stem cell variability and heterogeneity [J].
Cahan, Patrick ;
Daley, George Q. .
NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2013, 14 (06) :357-368
[9]  
Chen GK, 2011, NAT METHODS, V8, P424, DOI [10.1038/NMETH.1593, 10.1038/nmeth.1593]
[10]  
Cutts J, 2015, BIOMARK INSIGHTS, V10, P77, DOI [10.4137/BMIMI.S20313, 10.4137/BMI.S20313]